MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic value of olfactory dysfunction in Parkinson’s disease

K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)

Meeting: MDS Virtual Congress 2020

Abstract Number: 783

Keywords: Olfactory dysfunction

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To assess the olfactory performance in patients with PD using “Sniffin’ Sticks”.

Background: Olfactory dysfunction is an important early premotor biomarker for PD, and olfactory examination can be a key screening test to identify individuals at high risk for PD developing. However, the diagnostic value of the detection of hypo- and anosmia requires clarification.

Method: 2 groups: 1st – patients with PD (n=111) and 2nd – a control group (n=32 healthy volunteers) were formed in a prospective randomized study. The olfactory performance was assessed using the extended “Sniffin’ Sticks” test. Three parameters: olfactory threshold (T), odor identification (I) and odor discrimination (D) were determined. The maximum number of points that patient could score at each stage was 16, and in the general test – 48 (TDI-index=48).

Results: Hypo- or anosmia was observed in 87% of PD cases (violation of olfactory threshold – 77% and odor identification – 80%, table1). Olfactory dysfunction in PD was more pronounced in men (TDI-index – 16,8±2,7 points) compared with women (22,6±4,2, p<0,05).
Olfactory predictors of PD, according to the ROC analysis, were olfactory threshold – less than 4,0 (sensitivity 79,5% and specificity 69,75%); odor discrimination – less than 11,0 (70,6% and 78,5%, respectively); and the most effective – odor identification test – less than 13,0 (89,6% and 81,1%, respectively).
The level of olfaction in PD did not correlate with either the duration and the functional stage of the disease (table 2, p>0,05). The most pronounced impairment of olfaction in all modalities occurred in mixed and akinetic-rigid subtypes of PD, while the olfaction was more preserved in patients with a tremor-dominant PD (p<0,05).

Conclusion: Proposed quantitative indicators of olfactory tests (olfactory threshold, odors discrimination and identification) with high sensitivity and specificity can be used as additional non-motor diagnostic criteria for PD, but not applicable for monitoring the pathological process.

table1

table2

To cite this abstract in AMA style:

K. Stepanchenko, V. Marchenko, A. Zhidkova. Diagnostic value of olfactory dysfunction in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/diagnostic-value-of-olfactory-dysfunction-in-parkinsons-disease/. Accessed May 22, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-value-of-olfactory-dysfunction-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley